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Abstract
Background
Depression is known to be associated with cardiovascular diseases (CVD). This popula-
tion-based cohort study aimed to determine the association between depression of varying
severity and risk for CVD and to study the effect of concomitant anxious distress on this
association.
Methods
We utilized data from a longitudinal cohort study of mental health, work and relations among
adults (20–64 years), with a total of 10,443 individuals. Depression and anxious distress
were assessed using psychiatric rating scales and defined according to DSM-5. Outcomes
were register-based and self-reported cardiovascular diseases.
Findings
Overall increased odds ratios of 1.5 to 2.6 were seen for the different severity levels of
depression, with the highest adjusted OR for moderate depression (OR 2.1 (95% CI 1.3,
3.5). Similar odds ratios were seen for sub-groups of CVD: ischemic/hypertensive heart dis-
ease and stroke, 2.4 (95% CI 1.4, 3.9) and OR 2.1 (95%CI 1.2, 3.8) respectively. Depres-
sion with anxious distress as a specifier of severity showed OR of 2.1 (95% CI 1.5, 2.9) for
CVD.
Conclusion
This study found that severity level of depression seems to be of significance for increased
risk of CVD among depressed persons, although not in a dose-response manner which
might be obscured due to treatment of depression. Further, we found a higher risk of CVD
among depressed individuals with symptoms of anxious distress.
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Introduction
Depression is a large and increasing public health problem, and the majority of cases are not
detected in health care.[1] It is associated with increased risk of overall mortality and morbidity
such as cardiovascular-related outcomes, Alzheimer’s disease, obesity and cancer.[2]
Studies have been conducted to establish the temporal relationship between depression and
cardiovascular-related outcomes.[3–9] In a meta-analysis including 146,538 participants from
54 observational studies, Nicholson et al reported that it was difficult to establish whether
depression is a causal factor for coronary heart disease.[10] Studies need to be designed with
appropriate methodology to clarify the independent impact of interventions and comorbid dis-
ease on outcomes.[11] Depression has also been associated with stroke.[12,13] However there
is lack of data from studies where depression has been assessed by means of questionnaires val-
idated by interviews, thus ensuring that the symptoms are not purely part of a somatic disorder.
The dose-response relationship between depression and future risk of CVD has not been well
studied. So far there is are two studies that report incremental increase in the risk of future
CVD with increasing severity of depression. However both studies are based on patients from
hospital or clinic setting.[14,15]
More than half of the persons affected by depression also have symptoms of anxious dis-
tress, which is regarded as an indicator of severity of depression as it has been associated with
increased functional impairment, greater overall illness chronicity, and increased risk of sui-
cide.[16] Due to this clinical importance, anxious distress has been added as a specifier for
depressive disorders in the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)
giving the clinician the opportunity to rate not just the presence of such symptoms but also
their degree of severity. Anxious distress as a specifier of depression has not been studied in
relation to the future risk of CVD. Although there are studies on the association of anxiety as a
separate disease entity with CVD [17,18], less is known about whether the combination of
depression and anxious distress symptoms imposes a different risk of CVD than depression
alone.
This population-based cohort study aims to determine the association between depression
and risk for CVD, and to study the effect of severity of depression and concomitant symptoms
of anxious distress on this association.
Methods
Population and sample
Study design. We utilized data from the PART study (In Swedish short for: Psykisk hälsa,
Arbete och RelaTioner) which is a longitudinal cohort study of mental health, work and rela-
tions among adults (20–64 years) residing in Stockholm County, Sweden.[19] The PART study
has had three measurement points: wave 1 (W1) in 1998–2000, wave 2 (W2) in 2001–2003 and
wave 3 (W3) in 2010. During each wave, participants answered a postal questionnaire dealing
with the risk and protective factors of mental health and psychiatric rating scales. In the present
study, all participants fromW1 were followed up in W3 for occurrence of cardiovascular dis-
eases through self-reported outcomes and data in the National Patient Register (NPR) during
2008–2011.[20]
The Ethical Review Board at Karolinska Institutet, Stockholm, approved the study (case
number: 2010/1185-31/596:260, 01–218, 04-528/3 and 09–880). After a complete description
of the study to the subjects, written informed consent was obtained.
The PART study aimed to include 19,744 persons but only 19,457 could be reached, and
10,443 individuals responded to the questionnaire at W1 (participation rate 53%). Non-
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response analyses have been performed using available administrative registers, and participa-
tion was seen to be related to female gender, higher age, higher income and education, being
born in the Nordic countries and having no previous psychiatric diagnosis in inpatient regis-
ters.[21]
All participants received a second and third, almost identical questionnaire, three and ten
years after they had answered the first one (participation rate 83%, n = 8,622 in W2 and 61%,
n = 5,228 in W3). Attrition in the second wave was associated with similar factors to those in
the first wave. Additionally, participants with previous psychiatric hospital discharge diagnosis
at W1 had a higher probability of non-participation at W2 (OR 1.6 (95% CI 1.1, 2.4).[22] A
description of the study sample is given in “Table 1”.
Depression
Depression was assessed using the Major Depression Inventory (MDI) based on responses
given in W1 or W2. For those who were depressed in both W1 andW2, the wave in which they
scored highest MDI was used to assess level of severity. The MDI has shown high validity in
both clinical and non-clinical samples, including the PART study [23–25] and can also be used
as a diagnostic instrument with the algorithms for DSM-IV. The MDI scale comprises 10 ques-
tions on symptoms present nearly every day during the previous two weeks. Each question has
five response alternatives scored from 1–5 according to the presence of the symptom; all the
time (5), most of the time (4), slightly more than half of the time (3), slightly less than half of
the time (2), some of the time (1) and never (0). The sum score of all 10 questions ranges from
0–50.[26] In order to validate the MDI scale a subsample was interviewed by psychiatrists
using Schedules for Clinical Assessment in Neuropsychiatry. The study concluded that the
MDI score had a relatively high sensitivity (67%) for diagnosis of major depression.[23]
Severity of depression. Severity of depression was based on the MDI score and catego-
rized as follows: not depressed (MDI score< 20), mild depression (20–24), moderate (25–29)
and severe depression (MDI 30).[27]
Anxious distress: Anxious distress was defined according to DSM-V criteria and used as a
specifier for depression. This specifier is recommended to be used along with depression to
grade severity of depression.[28] The PART study was extensive and included multiple scales to
assess mental health. Anxious distress was based on specific items Appendix A in S1 Table) cor-
responding to the DSM-V from these scales. We combined the moderate-severe category with
severe as the severe category includes assessing motor agitation which requires a clinical obser-
vation.[29] Anxious distress was defined as the presence of at least two of the following symp-
toms during the previous two weeks: feeling keyed up or tense, feeling unusually restless,
difficulty in concentrating because of worry, fear that something awful might happen and fear
of losing self-control. Each symptom was assessed using a 5- or 6-point Likert scale, and, for
simplicity, the response alternatives were merged as yes or no, and rated according to DSM-5
number of symptoms (no anxious distress = none or one symptom; mild anxious distress = two
symptoms; moderate anxious distress = three symptoms; and moderate to severe anxious
distress = four to five symptoms)
Cardiovascular diseases
Cardiovascular disease (CVD) was assessed by self-reported health status questions in
W3.”Are you or have you previously been on treatment for angina pectoris or have you
received this diagnosis from a physician? “Corresponding questions were asked for myocardial
infarction, high blood pressure and stroke. In addition, hospital discharge diagnoses in the
National Patient Register (NPR) 2008 to 2011 were examined. The following diagnoses were
Depression and Cardiovascular Diseases
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coded in the NPR according to ICD10 [30,31]: ischemic/hypertensive heart disease; hyperten-
sive diseases (I11-13), ischemic heart diseases (I20-25), heart failure (I50), other peripheral vas-
cular diseases, embolism and thrombosis (I73-74) and stroke (I60-67 and I69).
Covariates
The following variables were selected as potential confounders: age, gender, socioeconomic
position (SEP), history of ischemic heart disease, hypertension, stroke and diabetes at baseline
(W1). The reason to consider these as confounders was that they are associated with the expo-
sure depression and cardiovascular outcomes and do not to come in the causal pathway (when
considered at baseline) between depression and CVD.[32–34] History of ischemic heart disease
Table 1. Characteristics of the participants overall, and stratified by depression status.
Overall Depressed1 Not depressed P value 2
N = 10341 N = 1488 (14.42) N = 8832 (85.58)
N (%) N (%) N (%)
Mean age (SD) in years 41.3 (12.4) 39.56 (11.9) 41.67 (12.5) <0.001
Male gender 4620 (44.0) 463 (31.1) 4146 (46.9) <0.001
Socio-economic position
High and intermediate level salary 4273 (41.2) 579 (52.4) 3679 (54.6)
Assistant –non manual workers 1359 (13.1) 197 (17.8) 1152 (17.1)
Skilled workers 609 (5.9) 79 (7.2) 529 (7.9)
Unskilled and semiskilled workers 991 (9.6) 146 (13.2) 832 (12.4)
Self-employed (other than professional) 649 (6.3) 103 (9.3) 543 (8.1) 0.38
IHD 193 (1.9) 47 (3.2) 143 (1.6) <0.001
Stroke 86 (0.8) 23 (1.5) 63 (0.7) 0.003
Hypertension 716 (6.9) 126 (8.5) 590 (6.7) 0.01
Diabetes mellitus 221 (2.1) 38 (2.6) 181 (2.0) 0.20
Smoking
Regular 1289 (12.4) 306 (24.5) 983 (13.6)
Occasional smoker 889 (8.6) 148 (11.9) 741 (10.3)
Ex-smoker 2502 (24.1) 331 (26.5) 2171 (30.0)
Never smoker 3796 (36.6) 462 (37.0) 3333 (46.1) <0.001
Physical activity 4574 (44.1) 550 (44.1) 4024 (55.4) <0.001
Mean BMI (SD) in kg/m2 24.97 (3.9) 25.13 (4.4) 24.93 (3.7) 0.1
Hazardous alcohol use 2605 (25.2) 544 (36.6) 2060 (23.3) <0.001
Sought treatment for psychiatric disorders 2365 (22.8) 821 (55.2) 1542 (17.5) <0.001
Severity of depression (MDI) 1
Mild - 534 (5.1) -
Moderate - 367 (3.5) -
Severe - 587 (5.6) -
Anxious distress symptoms
Mild 1729 (16.7) 539 (36.3) 1189 (13.5)
Moderate/severe 793 (7.7) 628 (42.3) 165 (1.9) <0.001
Cardiovascular diseases at follow-up 514 (5) 96 (6.5) 415 (4.7) 0.002
Ischemic/hypertensive heart at follow-up 364 (3.5) 64 (4.3) 297 (3.4) 0.04
Stroke at follow-up 228 (2.2) 49 (3.3) 179 (2) 0.001
1 Depression assessed by Major Depression inventory,
2Pearson chi square test and independent sample t test were used as appropriate.
doi:10.1371/journal.pone.0140742.t001
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and stroke were measured at W1 and were considered as previous history of CVD and the final
models were adjusted for them. We considered smoking, hazardous alcohol use, BMI and
physical activity as mediators since they are established risk factors for both depression and
CVD and are also likely to come in the causal pathway. [35–40] Age at W1 was categorized
into 30–45 years, 46–60 years, and 61–70 years and>71 years. SEP in W1 was measured
through occupational groups defined according to the Nordic Standard Occupational Classifi-
cation (NSOC) of 1989.[41] SEP was classified into five groups: high/intermediate level salaried
employees; assistant non-manual employees; skilled workers; unskilled workers; and self-
employed (including farmers). Participants were considered as physically active if they
reported exercise regularly at least three times a week. Smoking habits reported in W2 was clas-
sified as regular smoker, occasional smoker, previous smoker and never smoker.[42] Hazard-
ous alcohol use in W1 and W2 was assessed by the Alcohol Use Disorders Identification Test
(AUDIT) tool [43] and dichotomized following the Swedish cut-off points (8 points for men
and6 points for women).[44]. Treatment for psychiatric disorders was recorded through
questions inquiring whether the participant had sought psychiatric consultation in either W1
or W2. For those variables for which data was available from both W1 andW2, a combined
variable was created for both waves indicating presence in both waves or maximum value in
either wave for a continuous variable (e.g. body mass index (BMI) and hazardous alcohol
intake).
Statistical Analyses
Descriptive analyses were reported as mean and standard deviation (SD) for continuous vari-
ables and frequency and percentage for categorical variables. Imputation of missing values for
MDI and DSM-IV was performed when there were missing answers for one or two of the ten
questions. If answers were missing for more than two questions, the response was left as miss-
ing. The missing answers were imputed with the mean value of the questions in the answered
items. The number of missing answers for three or more questions was low, 0.2% (n = 23) in
W1 and 1.4% (n = 121) in W2. A similar strategy was used for imputation of anxious distress
although only for one missing answer. Missing values for other variables were treated as such
in the analyses.
Independent sample t-tests and chi-square tests were used to compare the depressed and
non-depressed. Logistic regression was used to calculate odds ratios (OR) and corresponding
95% confidence intervals (95%CI) for the association between depression and CVD, and
adjusting for confounders. We used those without depression in the main analyses as a refer-
ence group and for the sub-analyses including anxious distress, we used those with neither
depression nor anxious distress. The test of homogeneity for OR (Breslow-Day with Tarone's
adjustment) was used to determine if the association of depression with CVD differed across
different strata of anxious distress. SPSS version 19.11 and SAS 9.3 were used for the statistical
analyses.
Results
The prevalence of depression, according to MDI, was 14.4% (n = 1488): 5.2% (n = 534) had
mild, 3.5% (n = 367) had moderate and 5.7% (n = 587) had severe depression. Applying the
DSM-IV algorithm, the overall prevalence of depression was 7.6% (n = 790). Persons affected
by depression were slightly younger and more often females than those not affected. Persons
with severe depression reported seeking treatment for psychiatric disorders more often 16.9%
(n = 400) than those with moderate 8% (n = 189) or mild 9.8% (n = 232) depression. During
follow-up, the risk of CVD was 5% (n = 514), of which ischemic/hypertensive heart diseases
Depression and Cardiovascular Diseases
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was 3.5% (n = 364), stroke was 2.2% (n = 228) and 0.8% (n = 78) had both ischemic/hyperten-
sive heart disease and stroke.
Depression was associated with risk for CVD (OR 1.9 (95% CI 1.4, 2.5). The association
weakened somewhat after taking confounding factors into account (OR 1.7 (95% CI 1.2, 2.3)
but remained in the final model after adjusting for mediators (OR 1.5 (95% CI 1.1, 2.1)). Simi-
lar associations were found in CVD subgroups: with adjusted OR 1.5 (95% CI 1.0, 2.1) for
ischemic/hypertensive heart diseases and OR of 1.7 (95% CI 1.1, 2.6) for stroke “Table 2”. The
analysis was also done using the DSM IV algorithm for depression and the results were similar
to those from MDI.
Overall increased odds ratios of 1.5 to 2.6 were seen for the different severity levels of
depression, with the highest OR for moderate depression. The association seemed to be partly
explained by confounders in model 2 and mediators in the final model for mild and severe
depression whereas the OR for moderate depression remained with CVD (OR 2.1 (95% CI 1.3,
3.5).
Table 2 further shows the association between depression and symptoms of anxious distress
and CVD. When we analyzed the effect of the combination of depression with anxious distress,
increased OR of 2.1(95% CI 1.5, 2.9) was seen, which remained in the final model. When ana-
lyzing the effect of the combination of depression and level of anxious distress we found that
depression in combination with mild anxious distress was associated with CVD (adjusted OR
2.1 (95% CI 1.4, 3.3). This was also confirmed by running a homogeneity test (p value = 0.17).
Increased odds ratios were also seen for depression in combination with moderate/severe anx-
ious distress, although this was not statistically significant. Similar associations for risk of CVD
were also seen in the sub-groups of CVD, where adjusted OR for ischemic/hypertensive heart
diseases was 2.4 (95% CI 1.4, 3.9) and for stroke was OR of 2.3 (95% CI 1.3, 4.1).
Discussion
In this large cohort of 10,341 adults, we found an association between depression and the
future risk of CVD, similar across sub-groups of CVD, but less strong when taking socio-
demographic and lifestyle factors into account. We found that level of severity of depression
seems to matter for increased risk of CVD, although not in a dose-response manner which
might be obscured due to treatment of depression. Overall, moderately depressed persons
showed higher estimates for CVD compared to mildly and severely depressed. Further, we
found a higher risk of CVD among depressed who also suffered from anxious distress
symptoms.
The association between depression and incident CVD has been reported previously, and
our results are in line with previous findings although differences exist in population age and
the instruments used for assessing depression.[45] A meta-analysis including 28 studies and
comprising approximately 80,000 subjects concluded that depression is a risk factor for inci-
dent CVD.[46] Two meta-analyses on approximately 500,000 participants and 45 studies, pub-
lished specifically on the association of depression as a risk factor for stroke, concluded that
depression is associated with increased risk of incident stroke.[47,48] There have also been
reports using Swedish populations previously. Rahman et al, for example, in an elderly Swedish
population (selected and followed using the national inpatient register) reported a hazard ratio
of 1.76 (95%CI 1.14, 2.71) for the association of depression with ischemic stroke but no associa-
tion with coronary heart disease.[49] In contrast, we found an association of depression with
hypertensive/ischemic heart disease and stroke. The reason for this might be that the popula-
tion in our study was relatively younger and we took previous CVD related disorders into
account. It is likely that, for example, hypertension was treated only in outpatient care and thus
Depression and Cardiovascular Diseases
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the information was not available in the registers. In a 37-year follow-up study of Swedish
young men, an association was found between anxiety disorders and CVD but not with depres-
sion. However, as there was no intermediate assessment of participants in the above study dur-
ing the long follow-up period, this might have diluted the exposure status of depression.
Additionally, late onset depression was missed resulting in misclassification among partici-
pants with no depression[17].
Severity of depression and its association with future risk of CVD has been reported previ-
ously in two studies. In the Nova Scotia Health Survey–1995 (n = 1302) depression was
assessed as a continuous score by the center for epidemiological studies–depression scale and
found an independent, gradient effect between depression and incident coronary heart disease.
[14] Further, Seldenrijk et al reported from the Netherlands Study of Depression and Anxiety
Table 2. Odds ratio for cardiovascular disease by depression status and severity of depression and anxious distress (n = 10,341).
Cardiovascular diseases Ischemic/hypertensive heart
disease
Stroke
N = 514 N = 364 N = 228
Model 11 Model 22 Model 33 Model 11 Model 22 Model 33 Model 11 Model 22 Model 33
OR (95%) OR (95%) OR (95%) OR (95%) OR (95%) OR (95%) OR (95%) OR (95%) OR (95%)
Depression status (MDI)
No 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
Yes 1.9
(1.4,2.5)
1.7
(1.2,2.3)
1.5
(1.1,2.1)
1.8
(1.3,2.5)
1.6
(1.1,2.3)
1.5
(1.0,2.1)
2.0
(1.4,3.0)
1.8
(1.2,2.7)
1.7
(1.1,2.6)
Level of depression (MDI)
No depression 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
Mild depression 1.5
(0.98,2.5)
1.4
(0.8,2.3)
1.3
(0.8,2.2)
1.9
(1.1,3.3)
1.8
(1.0,3.1)
1.7
(1.0,3.0)
1.7
(0.9,3.3)
1.6
(0.8,3.1)
1.5
(0.7,3.0)
Moderate depression 2.6
(1.6,4.2)
2.3
(1.4,3.8)
2.1
(1.3,3.5)
2.1
(1.2,3.8)
1.8
(1.0,3.4)
1.7
(0.9,3.3)
2.7
(1.4,5.1)
2.4
(1.2,4.7)
2.2
(1.1,4.3)
Severe depression 1.7
(1.1,2.7)
1.5
(0.9,2.4)
1.3
(0.9,2.2)
1.4
(0.8,2.5)
1.2
(0.7,2.3)
1.1
(0.6,2.0)
1.9
(1.0,3.5)
1.6
(0.9,3.1)
1.5
(0.8,2.9)
Depression (MDI) with/without
symptoms of anxious distress
No depression or anxious distress 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
Depression without anxious distress 1.6
(0.8,3.0)
1.6
(0.8,3.1)
1.5
(0.7,2.9)
1.4
(0.6,3.2)
1.6
(0.7,3.5)
1.5
(0.6,3.4)
2.2
(1.0,4.8)
2.2
(1.0,5.0)
2.1
(0.9,4.7)
Depression with anxious distress 2.1
(1.5,2.9)
1.8
(1.2,2.5)
1.6
(1.1,2.3)
2.0
(1.4,3.0)
1.7
(1.1,2.6)
1.6
(1.0,2.4)
2.0
(1.3,3.1)
1.7
(1.1,2.7)
1.6
(1.0,2.6)
Depression (MDI) with/without
levels of anxious distress
No depression or anxious distress 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
Depression without anxious distress 1.5
(0.8,3.0)
1.6
(0.8,3.1)
1.5
(0.7,2.9)
1.4
(0.6,3.2)
1.6
(0.7,3.5)
1.5
(0.6,3.4)
2.2
(1.0,4.8)
2.2
(1.0,5.0)
2.1
(0.9,4.7)
Depression with mild anxious distress 2.7
(1.8,4.1)
2.3
(1.5,3.5)
2.1
(1.4,3.3)
3.0
(1.9,4.7)
2.5
(1.5,4.1)
2.4
(1.4,3.9)
2.7
(1.5,4.8)
2.3
(1.3,4.1)
2.1
(1.2,3.8)
Depression with moderate/severe
anxious distress
1.6
(1.0,2.5)
1.3
(1.4,2.3)
1.2
(0.7,2.0)
1.2
(0.7,2.3)
1.1
(0.6,2.0)
0.9
(0.5,1.8)
1.5
(0.7,2.8)
1.2
(0.6,2.5)
1.1
(0.6,2.3)
1Model 1 adjusted for age and gender,
2 Model 2 adjusted for age, gender, SEP, history of IHD, stroke, hypertension and diabetes,
3Model 3 adjusted for age and gender, SEP, history of IHD, stroke, hypertension and, diabetes smoking, physical activity, BMI and hazardous alcohol
consumption.
doi:10.1371/journal.pone.0140742.t002
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(n = 2510), based on individuals visiting primary and mental health clinics, a dose-response
association between severity of depression (measured by composite international diagnostic
interview) and CVD; HR (95%CI) of 1.4 (0.7,2.5) for mild depression, 2.5 (1.2,4.5) for moder-
ate depression and 3.04 (1.3,5.7) for severe depression.[15] In our study we did not find any
clear dose response relation between depression and CVD. We think this potentially could be
due to this study being population based with 10 year follow up, while the former two studies
are based on hospital, primary and mental health clinics. Also in the former study the propor-
tion of participants who were exposed to depression or anxiety was 78% while the correspond-
ing number in our study was 14%. Also we hypothesize that people with severe depression seek
treatment for psychiatric disorders more commonly than those with milder forms, which also
was the case in the present study. It likely that persons who are treated for depression are also
treated for somatic symptoms and advised to alter their life style thus reducing the risk factors
for CVD.[50] We might have over-adjusted our results as smoking, physical activity and BMI
might act as mediators rather than confounders, being risk factors for both depression and
CVD.
Depression manifests clinically through metabolic, immune-inflammatory, autonomic and
hypothalamic pituitary axis dysregulation all of which affect the incidence of CVD.[51] It is
often accompanied by cognitive impairment, silent brain infarcts and hemorrhages which are
linked to stroke.[52] Additionally brain-derived neurotrophic factor (BDNF) and sigma-1
receptor play a cardio- protective role in the pathophysiology of CVD and depression in animal
models and could serve as targets for therapy.[53] We also know that some anti-depressants
like the tricyclic antidepressants also increase the risk of cardiac arrhythmia.[54] In the present
study, data on treatment did not take into account the compliance and type of treatment
offered to the participants and thus might not be a true reflection of treatment status. On the
other hand, people with mild or moderate depression who did not seek treatment might have
increased risk of CVD.
We found that when anxious distress symptoms was present in depressed persons, it
increased the future risk of CVD, although not in a dose-response manner and not as clearly
for stroke. One potential explanation to the finding that the risk of future CVD was higher in
patients who were depressed with mild anxious distress compared to those with moderate to
severe anxious distress could be that the former tend to seek treatment more often.[50] This
might lead to fewer of the depressed individuals with mild anxious distress progress to more
morbidity. Studies on anxious distress as a severity indicator of depression have not been
reported to date, however there are many studies on anxiety as a separate disorder and its rela-
tion to CVD. Some cross-sectional studies have reported associations between anxiety and
CVD. [55–57]. In a longitudinal study by Gustad et al on 62,567 Norwegian adults, symptoms
of anxiety were associated with increased risk of incident heart failure [18] which is in agree-
ment with our study. However in the former study anxiety was assessed as a separate disease
entity while we assessed anxious distress in depressed persons as an indicator of severity. In
another prospective study of anxiety and incident stroke, on 6,019 participants from the First
National Health and Nutrition Examination Survey (NHANES I), higher anxiety symptom lev-
els were associated with an increased risk of incident stroke, independent of other risk factors,
including depression.[58] That study assessed symptoms of anxiety using a generalized wellbe-
ing schedule which is actually a validated scale for assessment of general well-being, while we
have used validated scales for anxiety distress following DSM-5 criteria.
The strength of this study lies in its longitudinal design, the use of a population-based sam-
ple and the use of the MDI, which is a validated scale for measuring depression. It is one of
very few studies on the level of severity of depression with concomitant anxious distress and
future risk of CVD. Our study also has some limitations that have to be acknowledged. The
Depression and Cardiovascular Diseases
PLOS ONE | DOI:10.1371/journal.pone.0140742 October 15, 2015 8 / 12
response rates in W1 were 53%, which is quite low [21] and the participation rate at the follow-
up phase (wave 3) 61% (n = 5,228). The follow-up rate in wave 3 was rather low leading to
potential underestimation of CVD outcomes. However, to overcome this problem, we also
used the national inpatient register for outcome assessment. We unfortunately also did not
have access to the migration or death register. Analysis of responders and non-responders
showed that those who had received in-patient psychiatric care were less likely to participate,
thus leading to a selection bias limiting the generalizability of the study.[22] We do not know if
the level of severity or treatment and confounders changed in the periods between the mea-
surement points W1, W2 andW3. This might have resulted in over- or under-estimation of
the associations. Although the cohort design we do not know the exact timing of the outcome
events, and hence the incidence rate ratios could not be calculated. However, as the outcomes
were not very common during follow-up we think the ORs have not been distorted and can be
interpreted as risks. There might also have been some participants who developed depression
in the period between W2 and W3. Although this study was able to adjust for common media-
tors and confounders, it did not offer the possibility to adjust for dyslipidemia, blood glucose,
type and use of antidepressants and their compliance due to lack of such data.
Conclusion
This study found that level of severity of depression seems to be significant for the risk of CVD,
although not in a dose-response manner which might be obscured due to treatment. Overall,
moderate depression showed the highest risk for CVD. Further, we found that concomitant
anxious distress seems to imply a higher risk for CVD. Thus, concomitant anxious distress is
not just a marker for an increased risk of a worse prognosis of depression but also a marker for
a future risk of CVD, which stresses the need to always include anxious distress in assessments
of depressed patients.
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